Variant report

Variant	esv3323230
Chromosome Location	chr12:26110310-26112858
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:467)
CpG islands
(count:794)
Chromatin interactive
region (count:2)
LncRNA
region (count:24)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:467 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr12:26111166-26111346	H1-hESC	embryonic stem cell:	n/a	n/a
2	BHLHE40	chr12:26111173-26111242	K562	blood:	n/a	n/a
3	BHLHE40	chr12:26112213-26112339	HepG2	liver:	n/a	chr12:26112227-26112243
4	BRCA1	chr12:26111108-26111522	Hela-S3	cervix:	n/a	n/a
5	BRCA1	chr12:26112175-26112984	Hela-S3	cervix:	n/a	n/a
6	BRCA1	chr12:26111365-26111532	HepG2	liver:	n/a	n/a
7	CCNT2	chr12:26111238-26112215	K562	blood:	n/a	n/a
8	CEBPB	chr12:26110907-26113412	Hela-S3	cervix:	n/a	n/a
9	CEBPB	chr12:26112585-26112981	IMR90	lung:	n/a	n/a
10	CEBPB	chr12:26111976-26112392	A549	lung:	n/a	n/a
11	CEBPB	chr12:26111890-26112243	HepG2	liver:	n/a	n/a
12	CEBPB	chr12:26111962-26112210	MCF-7	breast:	n/a	n/a
13	CEBPB	chr12:26112044-26112231	K562	blood:	n/a	n/a
14	CEBPB	chr12:26111874-26112285	IMR90	lung:	n/a	n/a
15	CEBPB	chr12:26112669-26112946	HepG2	liver:	n/a	n/a
16	CEBPB	chr12:26111997-26112283	A549	lung:	n/a	n/a
17	CEBPB	chr12:26111833-26112347	ECC-1	luminal epithelium:	n/a	n/a
18	CEBPB	chr12:26112527-26113059	A549	lung:	n/a	n/a
19	CEBPB	chr12:26111941-26112282	A549	lung:	n/a	n/a
20	CEBPB	chr12:26111886-26112248	HepG2	liver:	n/a	n/a
21	CEBPB	chr12:26112674-26112920	A549	lung:	n/a	n/a
22	CEBPB	chr12:26111941-26112234	H1-hESC	embryonic stem cell:	n/a	n/a
23	CEBPB	chr12:26111935-26112156	HepG2	liver:	n/a	n/a
24	CEBPB	chr12:26112002-26112163	ECC-1	luminal epithelium:	n/a	n/a
25	CEBPD	chr12:26111949-26112217	HepG2	liver:	n/a	n/a
26	CHD1	chr12:26112224-26112728	H1-hESC	embryonic stem cell:	n/a	n/a
27	CHD1	chr12:26111776-26111841	H1-hESC	embryonic stem cell:	n/a	n/a
28	CHD1	chr12:26110394-26114412	IMR90	lung:	n/a	chr12:26111241-26111251
29	CHD2	chr12:26111356-26111688	K562	blood:	n/a	n/a
30	CHD2	chr12:26110923-26111653	H1-hESC	embryonic stem cell:	n/a	chr12:26111241-26111251
31	CHD2	chr12:26110731-26113022	Hela-S3	cervix:	n/a	chr12:26111241-26111251
32	CHD2	chr12:26111193-26111675	HepG2	liver:	n/a	chr12:26111241-26111251
33	CHD2	chr12:26112283-26112306	H1-hESC	embryonic stem cell:	n/a	n/a
34	CREB1	chr12:26110975-26111517	H1-hESC	embryonic stem cell:	n/a	n/a
35	CREB1	chr12:26111004-26111511	K562	blood:	n/a	n/a
36	CREB1	chr12:26111109-26112471	A549	lung:	n/a	n/a
37	CREB1	chr12:26111027-26111852	HepG2	liver:	n/a	n/a
38	CREB1	chr12:26111163-26111483	H1-hESC	embryonic stem cell:	n/a	n/a
39	CTBP2	chr12:26111692-26112349	H1-hESC	embryonic stem cell:	n/a	n/a
40	CTBP2	chr12:26110974-26111479	H1-hESC	embryonic stem cell:	n/a	n/a
41	CTCF	chr12:26111443-26111486	MCF-7	breast:	n/a	n/a
42	CTCF	chr12:26112740-26112890	AG09309	skin:	n/a	n/a
43	CTCF	chr12:26111360-26111510	GM12874	blood:	n/a	n/a
44	CTCF	chr12:26112740-26112890	HMF	breast:	n/a	n/a
45	CTCF	chr12:26111360-26111510	GM12875	blood:	n/a	n/a
46	CTCF	chr12:26111373-26111558	SK-N-SH_RA	brain:	n/a	n/a
47	CTCF	chr12:26111380-26111530	HMEC	breast:	n/a	n/a
48	CTCF	chr12:26112700-26112850	Caco-2	colon:	n/a	n/a
49	CTCF	chr12:26112720-26112870	HMEC	breast:	n/a	n/a
50	CTCF	chr12:26112763-26112808	A549	lung:	n/a	n/a

(count:794 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:26111697-26111747	GM12892	blood:	n/a
2	chr12:26111697-26111747	GM12892	blood:	n/a
3	chr12:26110518-26110568	HRE	kidney:	n/a
4	chr12:26110666-26110716	HUVEC	blood vessel:	n/a
5	chr12:26110700-26110750	Hepatocyte	liver:	n/a
6	chr12:26112653-26112703	ECC-1	luminal epithelium:	n/a
7	chr12:26111162-26111212	HL-60	blood:	n/a
8	chr12:26111213-26111263	ProgFib	skin:	n/a
9	chr12:26112065-26112115	AoSMC	blood vessel:	n/a
10	chr12:26112454-26112504	Caco-2	colon:	n/a
11	chr12:26111697-26111747	U87	brain:	n/a
12	chr12:26111697-26111747	BE2_C	brain:	n/a
13	chr12:26111162-26111212	HMEC	breast:	n/a
14	chr12:26110518-26110568	AG04450	lung:	fetal
15	chr12:26110700-26110750	IMR90	lung:	fetal
16	chr12:26110518-26110568	NT2-D1	testis:	n/a
17	chr12:26110518-26110568	HAEpiC	amniotic membrane:	n/a
18	chr12:26111162-26111212	NT2-D1	testis:	n/a
19	chr12:26111348-26111398	SK-N-SH	brain:	n/a
20	chr12:26112653-26112703	MCF-7	breast:	n/a
21	chr12:26112065-26112115	HPAEpiC	pulmonary alveolar:	n/a
22	chr12:26111821-26111871	MCF-7	breast:	n/a
23	chr12:26111213-26111263	Hepatocyte	liver:	n/a
24	chr12:26110666-26110716	AG04450	lung:	fetal
25	chr12:26110518-26110568	SAEC	small airway:	n/a
26	chr12:26112121-26112171	HL-60	blood:	n/a
27	chr12:26112746-26112796	RPTEC	kidney:	n/a
28	chr12:26111821-26111871	Jurkat	blood:	n/a
29	chr12:26112121-26112171	LNCaP	prostate:	n/a
30	chr12:26110518-26110568	HCT-116	colon:	n/a
31	chr12:26110666-26110716	AG04449	skin:	fetal
32	chr12:26111162-26111212	HEK293	kidney:	embryo
33	chr12:26111162-26111212	MCF10A-Er-Src	breast:	n/a
34	chr12:26111348-26111398	PFSK-1	brain:	n/a
35	chr12:26111162-26111212	HRE	kidney:	n/a
36	chr12:26111821-26111871	PrEC	prostate:	n/a
37	chr12:26110666-26110716	HMEC	breast:	n/a
38	chr12:26112653-26112703	HCF	heart:	n/a
39	chr12:26111348-26111398	HIPEpiC	eye:	n/a
40	chr12:26110700-26110750	AG04450	lung:	fetal
41	chr12:26111213-26111263	HMEC	breast:	n/a
42	chr12:26110666-26110716	GM06990	blood:	n/a
43	chr12:26112065-26112115	H1-hESC	embryonic stem cell:	embryo
44	chr12:26112121-26112171	GM12891	blood:	n/a
45	chr12:26110666-26110716	SK-N-SH_RA	brain:	n/a
46	chr12:26112121-26112171	HAEpiC	amniotic membrane:	n/a
47	chr12:26112454-26112504	GM12891	blood:	n/a
48	chr12:26112746-26112796	HCF	heart:	n/a
49	chr12:26111213-26111263	NB4	blood:	n/a
50	chr12:26111162-26111212	ProgFib	skin:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr12:26110998..26111780-chr19:1251515..1252465,2	Hela-S3	cervix:
2	chr12:25986954..25988487-chr12:26111623..26114201,2	MCF-7	breast:

(count:24 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-BHLHE41-2	chr12:26111865-26111998	ENSG00000246695
2	lnc-SSPN-6	chr12:26111991-26112081	NONHSAT027385
3	lnc-BHLHE41-2	chr12:26110952-26111426	NONHSAT027381
4	lnc-BHLHE41-2	chr12:26110952-26111483	NONHSAT027384
5	lnc-BHLHE41-2	chr12:26112259-26112698	ENSG00000246695
6	lnc-SSPN-6	chr12:26112054-26112081	NONHSAT027387
7	lnc-SSPN-6	chr12:26112054-26112081	NONHSAT027388
8	lnc-BHLHE41-2	chr12:26110952-26111030	NONHSAT027371
9	lnc-BHLHE41-2	chr12:26110952-26111408	NONHSAT140062
10	lnc-BHLHE41-2	chr12:26112259-26112314	ENSG00000246695
11	lnc-BHLHE41-2	chr12:26110952-26111496	NONHSAT027366
12	lnc-BHLHE41-2	chr12:26112259-26112375	NR_038228
13	lnc-BHLHE41-2	chr12:26110386-26110518	ENSG00000246695
14	lnc-BHLHE41-2	chr12:26110386-26110429	NONHSAT027377
15	lnc-BHLHE41-2	chr12:26111865-26111998	ENSG00000246695
16	lnc-BHLHE41-2	chr12:26110386-26110518	ENSG00000246695
17	lnc-BHLHE41-2	chr12:26110952-26111426	NONHSAT027382
18	lnc-BHLHE41-2	chr12:26112259-26112375	ENSG00000246695
19	lnc-BHLHE41-2	chr12:26110952-26111511	ENSG00000246695
20	lnc-BHLHE41-2	chr12:26111865-26111975	ENSG00000246695
21	lnc-BHLHE41-2	chr12:26110386-26110433	NONHSAT027370
22	lnc-BHLHE41-2	chr12:26110952-26110979	ENSG00000246695
23	lnc-BHLHE41-2	chr12:26110952-26111408	NONHSAT027374
24	lnc-BHLHE41-2	chr12:26110386-26110518	NONHSAT027378

No data

Variant related genes	Relation type
RASSF8-AS1	TF binding region
RASSF8	TF binding region
RASSF8-AS1	CpG island
RASSF8	CpG island
ENSG00000256440	chromatin interactions
ENSG00000167470	chromatin interactions
NARS	miRNA target sites
PLEKHA5	miRNA target sites
RMND5A	miRNA target sites
VPS4B	miRNA target sites
RPH3AL	miRNA target sites
TMEM41A	miRNA target sites
ZADH2	miRNA target sites
KAT2B	miRNA target sites

Extended variants
information (count: 93 )
Associated
traits (count: 89 )

Variant overlapped rSNPs/rCNVs (count:93 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs146977652	chr12:26110342-26110343	Flanking Active TSS Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs565013828	chr12:26110372-26110373	Flanking Active TSS Enhancers Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs74448691	chr12:26110388-26110389	Flanking Active TSS Enhancers Weak transcription Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
4	rs79717396	chr12:26110408-26110409	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
5	rs540628599	chr12:26110428-26110429	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
6	rs76951545	chr12:26110443-26110444	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
7	rs368765054	chr12:26110444-26110445	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
8	rs140630853	chr12:26110457-26110458	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
9	rs4963944	chr12:26110484-26110485	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs181095410	chr12:26110501-26110502	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
11	rs113219994	chr12:26110518-26110519	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region CpG island lncRNA	2 gene(s)	Overlapped CNVs	n/a
12	rs185903838	chr12:26110547-26110548	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
13	rs552048701	chr12:26110565-26110566	Active TSS Enhancers Weak transcription Flanking Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
14	rs12424238	chr12:26110610-26110611	Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	mRNA abundance
15	rs556239224	chr12:26110616-26110617	Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
16	rs375107653	chr12:26110617-26110618	Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
17	rs374839856	chr12:26110642-26110643	Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
18	rs535075234	chr12:26110653-26110654	Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
19	rs73074872	chr12:26110681-26110682	Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region CpG island	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs568458133	chr12:26110735-26110736	Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
21	rs190361746	chr12:26110747-26110748	Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
22	rs183349828	chr12:26110769-26110770	Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
23	rs565843363	chr12:26110787-26110788	Active TSS Flanking Active TSS Weak transcription Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
24	rs540039733	chr12:26110849-26110850	Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
25	rs3803010	chr12:26110876-26110877	Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
26	rs35639226	chr12:26110877-26110878	Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
27	rs187854934	chr12:26110888-26110889	Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
28	rs150454961	chr12:26110903-26110904	Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
29	rs552583074	chr12:26110919-26110920	Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
30	rs539263776	chr12:26110934-26110935	Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
31	rs145373780	chr12:26110955-26110956	Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
32	rs141579938	chr12:26110978-26110979	Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
33	rs541394478	chr12:26110988-26110989	Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region lncRNA	2 gene(s)	Overlapped CNVs	n/a
34	rs376164641	chr12:26111000-26111001	Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Bivalent/Poised TSS ZNF genes & repeats	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
35	rs563804132	chr12:26111117-26111118	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
36	rs79213154	chr12:26111125-26111126	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
37	rs530673580	chr12:26111134-26111135	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
38	rs545983768	chr12:26111161-26111162	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
39	rs370247893	chr12:26111179-26111180	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
40	rs528639952	chr12:26111193-26111194	Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
41	rs547101810	chr12:26111221-26111222	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
42	rs568496917	chr12:26111286-26111287	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
43	rs149047907	chr12:26111293-26111294	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
44	rs550666020	chr12:26111318-26111319	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
45	rs569543743	chr12:26111393-26111394	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
46	rs533183570	chr12:26111567-26111568	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
47	rs555340450	chr12:26111571-26111572	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
48	rs706519	chr12:26111576-26111577	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
49	rs539739864	chr12:26111648-26111649	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
50	rs113005451	chr12:26111693-26111694	Active TSS Weak transcription Enhancers Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:89)

Disease	PMID	Source
Malignant germ cell tumour	17285132	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Myxofibrosarcoma	16751306	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Acute myeloid leukemia	16864856	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21858162	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Myelodysplastic syndrome	21251322	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Cancer	20164919	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	17133270	CNVD
Ependymoma	18628472	CNVD
Leukemia	18628472	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	16397240	CNVD
Neurodevelopmental disorder	22521361	CNVD
Intracranial aneurysm	16715129	CNVD
Breast cancer	21509527	CNVD
Autism	22102821	CNVD
Follicular lymphoma	18703704	CNVD
Lung cancer	18438408	CNVD
Lung cancer	21911935	CNVD
Breast cancer	22048815	CNVD
Malignant peripheral nerve sheath tumor	19844265	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Heart disease	21282601	CNVD
Ovarian cancer	20844748	CNVD
Lung cancer	17925434	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Gastric cancer	24379144	CNVD
Gastric cancer	19545448	CNVD
Lung cancer	20031968	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung adenocarcinoma	19826477	CNVD
Lung cancer	19525976	CNVD
Lung cancer	19826477	CNVD
Non-small cell lung cancer	19451690	CNVD
Non-small cell lung cancer	17504988	CNVD
Bipolar disorder	19114987	CNVD
Lung cancer	19671679	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	21364760	CNVD
Lung cancer	21569311	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:361 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:26085400-26110600	Weak transcription	Aorta	Aorta
2	chr12:26086800-26110600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
3	chr12:26092000-26110600	Weak transcription	Skeletal Muscle Male	skeletal muscle
4	chr12:26093400-26110400	Weak transcription	Cortex derived primary cultured neurospheres	brain
5	chr12:26095800-26111000	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
6	chr12:26097400-26110600	Weak transcription	Right Ventricle	heart
7	chr12:26097600-26110400	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
8	chr12:26101400-26110600	Weak transcription	Placenta	Placenta
9	chr12:26104000-26110600	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
10	chr12:26104200-26110600	Weak transcription	Liver	Liver
11	chr12:26104400-26110400	Weak transcription	Stomach Smooth Muscle	stomach
12	chr12:26105800-26110600	Weak transcription	Fetal Intestine Small	intestine
13	chr12:26105800-26110600	Weak transcription	HSMMtube	muscle
14	chr12:26106000-26110800	Weak transcription	Colon Smooth Muscle	Colon
15	chr12:26106400-26110600	Weak transcription	Adipose Nuclei	Adipose
16	chr12:26106400-26110600	Weak transcription	Brain Inferior Temporal Lobe	brain
17	chr12:26106800-26110600	Weak transcription	Fetal Intestine Large	intestine
18	chr12:26107400-26110600	Weak transcription	Left Ventricle	heart
19	chr12:26107600-26110400	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
20	chr12:26108000-26110600	Weak transcription	Brain Angular Gyrus	brain
21	chr12:26108000-26110600	Weak transcription	Fetal Stomach	stomach
22	chr12:26108400-26110400	Weak transcription	Fetal Muscle Trunk	muscle
23	chr12:26108800-26110600	Weak transcription	Duodenum Smooth Muscle	Duodenum
24	chr12:26109000-26110600	Weak transcription	Brain Hippocampus Middle	brain
25	chr12:26109200-26110400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
26	chr12:26109400-26110400	Enhancers	iPS-15b Cell Line	embryonic stem cell
27	chr12:26110000-26110400	Enhancers	Breast Myoepithelial Primary Cells	Breast
28	chr12:26110000-26110400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
29	chr12:26110000-26110600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
30	chr12:26110000-26110600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
31	chr12:26110000-26110600	Enhancers	Psoas Muscle	Psoas
32	chr12:26110000-26110600	Enhancers	NHLF	lung
33	chr12:26110000-26110800	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
34	chr12:26110000-26111000	Flanking Active TSS	Hela-S3	cervix
35	chr12:26110000-26113600	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
36	chr12:26110200-26110400	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
37	chr12:26110200-26110400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
38	chr12:26110200-26110400	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
39	chr12:26110200-26110400	Enhancers	HUES64 Cell Line	embryonic stem cell
40	chr12:26110200-26110400	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
41	chr12:26110200-26110400	Enhancers	Brain Substantia Nigra	brain
42	chr12:26110200-26110400	Flanking Active TSS	Fetal Kidney	kidney
43	chr12:26110200-26110400	Flanking Active TSS	Pancreatic Islets	Pancreatic Islet
44	chr12:26110200-26110400	Enhancers	HSMM	muscle
45	chr12:26110200-26110400	Enhancers	HUVEC	blood vessel
46	chr12:26110200-26110600	Enhancers	H1 Cell Line	embryonic stem cell
47	chr12:26110200-26110600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
48	chr12:26110200-26110600	Flanking Active TSS	iPS-18 Cell Line	embryonic stem cell
49	chr12:26110200-26110600	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
50	chr12:26110200-26110600	Enhancers	Brain Anterior Caudate	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links